Table 2.
Hepatic mRNA levels in Atlantic salmon exposed to 24 and 48 h SW exposures in two separate experiments (March and May)
| Target Gene | Experiment | 0 h | 24 h | 48 h |
|---|---|---|---|---|
| ghr1 | March | 1.00 ± 0.30a,b | 0.36 ± 0.04b | 1.95 ± 0.55a |
| May | 1.00 ± 0.14 | 5.38 ± 4.00 | 1.79 ± 0.25 | |
| igf1 | March | 1.00 ± 0.21 | 0.67 ± 0.22 | 0.84 ± 0.30 |
| May | 1.00 ± 0.04b | 0.61 ± 0.17b | 1.55 ± 0.15a | |
| igf2 | March | 1.00 ± 0.27 | 0.63 ± 0.14 | 0.72 ± 0.20 |
| May | 1.00 ± 0.19 | 4.39 ± 3.35 | 0.95 ± 0.27 | |
| igfbp1a1 | March | 1.00 ± 0.44b | 6.06 ± 2.81a,b | 20.15 ± 8.67a |
| May | 1.00 ± 0.39 | 20.26 ± 10.23 | 144.97 ± 88.44 | |
| igfbp1b1 | March | 1.00 ± 0.21b | 4.45 ± 0.39a | 4.55 ± 1.15a |
| May | 1.00 ± 0.13 | 0.79 ± 0.09 | 1.38 ± 0.47 | |
| igfbp1b2 | March | 1.00 ± 0.16 | 2.41 ± 0.31 | 2.79 ± 0.89 |
| May | 1.00 ± 0.14a | 0.52 ± 0.04b | 1.24 ± 0.21a | |
| igfbp2a | March | 1.00 ± 0.10 | 0.98 ± 0.22 | 0.84 ± 0.17 |
| May | 1.00 ± 0.09 | 0.85 ± 0.11 | 1.27 ± 0.23 | |
| igfbp2b1 | March | 1.00 ± 0.10 | 0.91 ± 0.06 | 0.65 ± 0.12 |
| May | 1.00 ± 0.11 | 1.02 ± 0.14 | 1.53 ± 0.32 | |
| igfbp2b2 | March | 1.00 ± 0.12 | 0.87 ± 0.06 | 0.97 ± 0.13 |
| May | 1.00 ± 0.09 | 0.82 ± 0.10 | 0.91 ± 0.19 |
Expression levels are presented as a fold-change from the 0 h groups. Means ± S.E.M. (n = 8). Within an experiment, means not sharing the same superscript letter are significantly different (one-way ANOVA, Tukey’s HSD test, P < 0.05)